Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_assertion type Assertion NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_head.
- NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_assertion description "[Tyrosine kinase inhibitors (TKIs) have demonstrated success in the treatment of acute lymphoblastic leukemia (ALL) in patients that express BCR-ABL rearrangements (Philadelphia chromosome [Ph]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_provenance.
- NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_assertion evidence source_evidence_literature NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_provenance.
- NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_assertion SIO_000772 25415187 NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_provenance.
- NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_assertion wasDerivedFrom befree-2016 NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_provenance.
- NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_assertion wasGeneratedBy ECO_0000203 NP1239088.RAASDRyXTv1bjptj2uvQMOFbyc7B6raIeVsbZoqzzWWsQ130_provenance.